Table 3 Presents the antigenicity, allergenicity, and toxicity of the final selected HTL dominant epitopes.
Peptide | Allele | Peptide length | Start | End | Antigenicity | Allergenicity | Toxicity | |
|---|---|---|---|---|---|---|---|---|
VirB2 | LIVSIAAIEPNLAHA | HLA-DRB1*15:01 | 15 | 22 | 36 | 0.7921 | NON-ALLERGEN | Non-Toxin |
LGGALVVGAAAEIAS | HLA-DRB1*07:01 | 15 | 87 | 101 | 0.5069 | NON-ALLERGEN | Non-Toxin | |
VirB3 | RPAMLFGVPVIPLVI | HLA-DRB1*07:01 | 15 | 26 | 40 | 0.8718 | NON-ALLERGEN | Non-Toxin |
VirB6 | PSSTIYQTLDNSLGK | HLA-DRB1*07:01 | 15 | 110 | 124 | 0.5911 | NON-ALLERGEN | Non-Toxin |
BtpA | EYDFFISHASEDKEA | HLA-DRB1*07:01 | 15 | 118 | 132 | 0.8237 | NON-ALLERGEN | Non-Toxin |
KAKQLSSYQAKQFKA | HLA-DRB1*15:01 | 15 | 58 | 72 | 0.6716 | NON-ALLERGEN | Non-Toxin |
